The proliferation and easy access to drugs in the world today has significant impact on the psychology and social world of the individual. “Any substance that can change a mood or state of mind is called a psychoactive or mood-altering drug. Using psychoactive drugs can escalate into an addiction, which is a physical or psychological dependence on the drug. With psychological dependence, a person needs to keep taking a drug to get its effects. A physical dependence means that if someone stops taking the drug, withdrawal symptoms occur and the person feels uncomfortable or sick. Some people have both types of drug dependence (Monroe, 1994). Alcohol is considered a drug under the above definition. Other common drugs include marijuana, heroine, cocaine and it’s derivative, crack, LSD and other stimulant drugs.
Individuals who suffer from addictions, or substance abuse disorders, often have comorbid mental disorders that may be primary or secondary in the etiology of their addiction (Khantzian, 1985); (Kosten and Rounsaville, 1986); (Kranzler and Liebowitz, 1988); (Ross, et al, 1988);(Rounsaville, et al, 1982). The combination of drug dependence and psychopathology is an important treatment consideration. The implications of the interaction of the addiction with the pathology in the context of the addict’s environment is of acute importance in the planning and implementation of treatment. Implications concerning expected outcomes may be interrelated as well. “Researchers and clinicians view accompanying psychopathology as having a significant impact on a drug-dependent person’s addiction patterns and ability to become drug-free and avoid relapse. The research demonstrates that opiate addiction … is most often associated with other comorbid psychopathology. It suggests a need for thorough assessment for general psychopathology in … addicts entering addiction treatment, especially assessment for anxiety and affective disorders. It also suggests the need for treatment that focuses on diagnosed mental disorders in addition to drug counseling for the substance abuse disorder” (Milby, et al, 1996, pp. 95).
Many managed health care organizations are cutting funding for standard psychological testing for purposes of assessment and treatment of individuals diagnosed with an alcohol or other drug use disorder. However, there is limited empirical information about the short-term stability of neuropsychological status and other characteristics that are useful to assess early in treatment. A study completed in 1997 examined the stability of neuropsychological test scores within the first 3 weeks following diagnosis of an alcohol use disorder. Early assessments of neuropsychological status were psychometrically stable, and also provided reasonably stable indicants of clinically significant impairment(Bates, 1997).Streamlined health care delivery systems and reduced insurance for treatment of substance use disorders require that treatment decisions must often be made in a timely fashion (Meek et al., 1989). “The ability to obtain valid neuropsychological data shortly after alcohol problem identification may enhance the design of clinical research by allowing assessments of clients’ impairment to be closely linked in time to the start of treatment. This seems particularly important for understanding the impact of neurocognitive impairment on successful outcomes within new treatment delivery systems that emphasize short-term traditional treatment plans, outpatient care and an increasing variety of brief interventions” (Bates, 1997, pp. 21). These trends suggest that valid information regarding neurocognitive status can be obtained, the more useful it may be to inform clinical decision making (Weinstein and Shaffer, 1993). Research aimed at understanding the prognostic significance of
neuropsychological deficit to treatment process and outcome can also be used or efficient clinical decision making (Bates, 1993).
“Traditionally, both psychologists performing testing as well as recipients of testing had free rein in both the types and number of tests given, as well as in the time allotted for testing and report writing. I t was not uncommon for psychologists to give entire batteries of tests, including IQ tests, projective tests, neuropsychological tests, and educational tests, as well as various personality inventories and mood scales. They quite commonly requested tests specific to language impairments, vocational aptitudes, sexual dysfunction, and even ADD and ADHD in adults, to name a few. However questionable they may have been to outsiders, these batteries were often deemed an absolute necessity by professionals seeking answers about a patient’s functioning, level of impairment and/or behavior” (Werthman, 1995, pp. 15).
In addition to the consideration of cost in time and money, the increase in brief therapy modalities and an inclination to more short term hospitalization within the mental health arena, leads more professionals to the opinion that less testing is required. Testing should be specific to the presenting problem and expanding on the basis of history and behavior. Managed care has caused professionals to revisit the medical necessity and efficacy of their testing practices. Currently, the emphasis is on the use of highly targeted and focused psychological and neuropsychological testing to sharply define the “problems” to be treated, the degree of impairment, the level of care to be provided and the treatment plan to be implemented. The high specificity and “problem-solving” approach of such testing reflects the commitment to effecting therapeutic change, as opposed to obtaining a descriptive narrative with scores. Testing is perceived as a strong tool for assisting the professional in more accurately diagnosing and subsequent recommendation of treatment alternatives (Werthman, 1995).
Providers often have difficulty in accurately assessing or ruling out dementia and other neuropsychological impairments. This is particularly true when there is a co-existing primary Axis I diagnosis of substance dependence. In addressing such dilemmas initial assessment is used to determine which of the neuropsychological tests is appropriate and/or which parts of the Wechsler scales might be necessary to assist the provider in managing the case. Frequently, specific parts of tests or individual tests, rather than entire batteries, can provide the diagnostic information necessary for the initial identification of patient problems and concurrent treatment planning. Testing is a “tool” used to augment the clinical expertise and diagnostic resources of the primary provider. This trend has been most evident in the assessment of individuals believed to be suffering from organicity, concurrent with a psychiatric diagnosis and with individuals having dual diagnoses such as psychiatric and substance abuse and, or, dependence (Werthman, 1995). The term, “dual diagnosis” is often used interchangeably with “psychopathology” but they are separate concepts.
The psychopathology of drug addiction can be defined under four-type-based classifications of drug abusers: Type A addicts (adjustment disorders) present an evident relation between the external event, psychic trauma, and drug-abusing behavior. Type B (neurotic disorders) have a tendency to reduce internal anxiety by drug abuse, and their personal problems may be covered by drug use. Type C (psychosis and borderline) are a heterogeneous group, where often drug use can create an intense experience of inner freedom. Type D (sociopathic personality disorders) often express their psychic conflicts by means of serious acting-out, and come from families were ‘nonexistent’ marriages were established. Family structure and functionality underlies such personality types. The typology of drug addicts may shed light on prevention and therapy, whereas more specific therapeutic programs are needed (Cancrini, 1994). The importance of psychological testing to identify the existance, type and scope of the psychopathology is paramount. The implications for prevention, early detection and treatment are inherent in the incidence of comorbid addictions as shown in the many studies on the inter relatedness of addiction, behavior and psychopathology.
Since the 1970s, researchers have begun systematic investigations of the differential characteristics of narcotic addicts. As a consequence, addicts have been classified on many dimensions, including type, frequency, and severity of criminal behavior (Nurco, et al, 1991), opportunity and motivation to use narcotic drugs (Nurco, et al, 1981) and extent and severity of psychiatric problems (McLellan, et al, 1983). “Gender and ethnic differences have also been found to have an important bearing on treatment planning. Female addicts, for example, are more likely than male addicts to experience health problems, whereas male addicts are more likely to abuse drugs and commit crime while in treatment With respect to ethnicity, black and white addicts tend to have different patterns of nonnarcotic drug use” (Nurco, et al, 1997, pp. 523). Behaviors and experiences occurring after the onset of narcotic addiction have been the primary focus of classifications of narcotic addicts derived to date. While these typologies are valuable for developing intervention strategies for different types of individuals, they have ignored variations in precursors to addiction that are relevant to subsequent addiction status. The identification of these precursors would be valuable for both prevention and early intervention purposes by providing information on early manifestations and correlates of problem behavior exhibited by adult narcotic addicts. (Nurco, et al, 1997) Findings have suggested the usefulness of examining information on early adolescent activity, perceptions, and experiences in five major areas: family; peer associates; deviance proneness; psychological status; and protective, or resilient, features. In any given case, treatment efforts should be guided by the extent to which each of these areas impacts on the individual’s development and current status. (Nurco, et al, 1997). The inclusion of psychological status as one of the major areas is indicative of the importance of psychological testing in early intervention and prevention of subsequent drug addiction.
Khantzian (1985) proposes that opiate-dependent individuals are attracted to their drug of choice because of its effectiveness in altering prevailing aversive emotional states. He suggests the drug addict’s choice of a substance provides a substitute for lack of satisfactory internal emotional control. Behavioral anomalies such as conduct disorder and antisocial personality are often found to be associated with alcohol and drug problems. Several investigators have noted that sociopathic behavior in children predicts a tendency toward antisocial personality behavior, alcohol abuse and drug problems later in life. An analysis of 40 studies showed a strong positive correlation between alcoholism and drug abuse, between alcoholism and antisocial personality, and between drug abuse and antisocial personality (Schubert et al. 1988).
In a study done with 252 male methadone maintained patients to determine profiles based on four continuous measures of antisociality: 1) childhood conduct disorder; 2) adult antisocial personality disorder symptoms; t3) the revised Psychopathy Checklist; and 4) the Socialization scale of the California Psychological Inventory, it was determined that the expression of antisociality supported the validity of a more complex conceptualization of antisociality than is provided by antisocial personality disorder. The study identified six replicable and temporally stable cluster groups varying in degree and pattern of antisociality. The external criterion variable that were used were: the Addiction Severity Index measures of past and recent substance abuse; functioning and lifetime criminal history; Axis I and II symptomatology, anxiety and depression, object relations and reality testing, hostility, guilt, and machiavellianism (Alterman, et al, 1998). The implications of the study on treatment will be in assessing sociality and implementing appropriate strategies for extinguishing anti-social behavior associated with the addictive behavior.
The relationship of African Self-Consciousness (ASC) to misorientation behavior as evidenced in African American males who are addicted to crack and/or cocaine was the subject of a study done to gain a broader understanding of Azibo nosology. The substance addiction is counted as a self-destructive disorder and is considered an underlying factor in Azibo nosology. It is believed to be correlated with psychological misorientation in the pathology of African personality theory (Dixon and Azibo, 1998). Culturalization issues and the propensity to addiction of African males exhibiting misorientation behavior can be addressed in terms of prevention of substance abuse in this particular group.
The role of the primary care physician in diagnosing, treatment and recovery of substance abuse is primarily seen as initially support, information and referral and subsequent management of drug-related psychological conditions such as depression and anxiety and drug management using methadone, naltrexone and disulfiram may also be effective. The area where the physician can be the most effective is in the instance of recovering addicts who may seek out the physician for complaints associated with the addiction (Friedmann, et al, 1998). These patients may have achieved abstinence through completion of an addiction treatment program, attendance at a self-help program, or on their own (Sobell, et al, 1996). The clinical examination may provide some clues (e.g., spider nevi, scars from needle tracks) to the history of substance use problems, but it is not a substitute for nonjudgmental, direct questioning and testing for co-morbid disorders that are the province of a psychologist or psychologist. Referrals to other health professionals will initiate the process of establishing a multi-disciplinary team that can assess and recommend alternatives on all levels of the individual’s social, psychological and physical needs in treating the addiction, other psychological disorders and physical complaints in addition to facilitating the recovery process.
One of the roles the unconscious plays in addiction is that of the underlying fantasy process. Studies suggest that unconscious fantasies play a determining role in persisting patterns of substance abuse and addiction. Addiction is seen as both a derivative of the persistence of these unresolved fantasies and as an inadequate compromise formation. Given these suggestions, relapse can be seen as a manifestation of the episodic reassertion and influence of these powerful fantasies (Cattano, 1996). The role of testing is to determine the existence and extent of the underlying fantasy and to facilitate successful treatment by providing the foundational information necessary to work through the underlying fantasy process and the establishment
of healthier compromise formations.
A study done in 1995 indicates that coping styles are related to psychopathology. In many instances, the coping mechanism of choice is alcohol or substance abuse. Testing to determine the etiology of the pathology is conducive to understanding the addictive behavior. It is frequently beneficial to treat the underlying pathology in an effort to aide treatment and recovery (Belding, et al, 1996).
Many of the studies done in the field of pharmacology suggest that there is a correlation between addictive traits and the functioning of the neuroprocessors strongly affected by dopamine or seratonin inhibitors. There is reason to believe that a pharmacological approach could help people with reward deficiency syndrome. Studies suggest that the pharmacological sensitivity of alcoholics to dopaminergic agonists may be partly determined by the individual’s genotype. The use of these compounds is suggested in the treatment of alcoholics or stimulant-dependent people. One study has already shown that the use of dopaminergic agonists with rat populations significantly suppresses the animal’s symptoms after the withdrawal of opiates (Harris and Aston-Jones, 1994). These results strongly suggest an interrelationship between the addicts neuroresponses and the those of mood and behavior disordered individuals.
Unlike certain other complex disorders, such as Alzheimer’s disease, the early identification and treatment of alcohol and drug abuse can occasionally alter the devastating course of these addictions. Consider the successes of self-help programs such as Alcoholics Anonymous and Narcotics Anonymous, psychopharmacological adjunctive therapy, neuroregulation or brain-wave training and electrophysiological stimulation. Identifying individual’s high probability of addiction potential offers the possibility of helping individuals before alcoholism or substance abuse affects their lives. There is new hope for better treatment, new forms of prevention and the removal of the social stigma attached not only to alcoholism but also to related “reward-seeking”, or addictive behaviors (Blum, et al, 1996). Diagnosis of neurological etiology as opposed to psychopathological foundations are dependent upon both a thorough physical examination and psychological testing. As with other diagnosis that are treated pharmacologically, the process of treatment must address all aspects of the problem.
Psychological testing is used when there is a need to clarify a therapeutic situation. In the case of alcohol and, or substance abuse, it is important to determine whether there is an incidence of dual diagnosis, psychopathology to the addiction or a neurobiological etiology. The medical professional conducts an initial assessment to determine if there exists evidence of psychotic processes, suicidality, homicidality - or even any symptoms of depression.
The process of interviewing the individual and any persons available who might have knowledge of the individual’s behavior is implemented before more extensive testing is recommended. The professional looks for indications of behaviors usually attributed to conduct disorders, for example: evasiveness, neglect of responsibilities, stealing, lying, and aggressive behaviors such as initiating fights. Involvement with law enforcement and history of therapeutic interventions are also inquired about. Questions concerning physical and medical history are appropriate as well. Once the initial assessment is complete, the physician, psychologist or other professional is more prepared to suggest the appropriate testing for the individual.
Studies concerning alcohol and substance abuse indicate a high occurrence of personality, conduct and psychological disorders. There are indications that the misuse and addiction of substances is only one component in a myriad of influences on the individual. Efficient initial assessment techniques and the use of psychological testing can determine the proper course for treatment and recovery. Testing can also be implemented as a tool in prevention of substance abuse by the early detection and treatment of interrelated psychological problems.
REFERENCES
Alterman, Arthur I.; McDermott, Paul A.; Cacciola, John S.; Rutherford, Megan J.; Boardamn, Chris R.; McKay, James R.; Cook, Terry G. (1998, August). A Typology Of Antisociality In Methadone Patients. Journal of Abnormal Psychology, vol. 107(3) pp. 412(11).
Bates, Marsha E. (1997, November). Stability Of Neuropsychological Assessments Early In Alcoholism Treatment. Journal of Studies on Alcohol, vol. 58(6), pp. 617(5).
Blum, Kenneth; Cull, John G.; Braverman, Eric R.; Comings,David E. (1996, March). Reward Deficiency Syndrome. American Scientist, vol. 84(20, pp. 132(14).
Cancrini, Luigi (1994, September). The Psychopathology Of Drug Addiction: A Review. Journal of Drug Issues, vol. 24(4), pp. 597(26).
Cattano, Joseph A. (1996, December). The Influence Of Unconscious Fantasy Process In Addictions And Relapse. Clinical Social Work Journal, vol. 24(4), pp. 429(14).
Dixon, Patricia and Azibo, Daudi Ajani ya (1998, May). African Self-Consciousness, Misorientation Behavior, And A Self-Destructive Disorder: African American Male Crack-Cocaine Users. Journal of Black Psychology, vol. 24(2), pp. 226(22).
Friedmann, Peter D.; Saitz, Richard; Samet, Jeffrey H. (1998, April). Management Of Adults Recovering From Alcohol Or Other Drug Problems: Relapse Prevention In Primary Care. JAMA, The Journal of the American Medical Association, vol. 279(15), pp. 1227(5).
Harris, G. C., and G. Aston-Jones (1994). Involvement Of D2 Dopamine Receptors In Then Ucleus Accumbens In The Opiate Withdrawal Syndrome. Nature, vol. 371(6493), pp. 155(2).
Khantzian, E. J.(1985). The Self-Medication Hypothesis Of Addictive Disorders: Focus On Heroin And Cocaine Dependence. American Journal of Psychiatry, vol. 142, pp. 1259(5).
Kosten, T. R., and Rounsaville, B. J. (1986). Psychopathology In Opioid Addicts. Psychiatric Clinics of North America, vol. 9, pp. 515(17).
Kranzler, H. R., and Liebowitz, N. R.(1988). Anxiety And Depression In Substance Abuse: Clinical Implications. Medical Clinics of North America, vol. 72, pp. 867(18)
McLellan, A. T.; Luborsky, L.; Woody, G. E.; O’Brien, C. P. (1983). Predicting Response To Alcohol And Drug Abuse Treatments: Role Of Psychiatric Severity. Arch. General Psychiatry, vol. 9, pp. 620(5).
Meek, P.S.; Clark, H.W. and Solano, V.L. (1989). Neurocognitive Impairment: The Unrecognized Component Of Dual Diagnosis In Substance Abuse Treatment. Journal of Psychoactive Drugs, vol. 21, pp. 153(7).
Milby, Jesse B.; Sims,Mary K.; Khuder,Sadik; Schumacher,Joseph E.; Huggins,Norman; McLellan,A. Thomas; Woody,George; Haas,Neil (1996, February). Psychiatric Comorbidity: Prevalence In Methadone Maintenance Treatment. American Journal of Drug and Alcohol Abuse, vol. 22(1), pp. 95(13).
Monroe, Judy (1996, January). What is Addiction? Current Health, vol. 22(5), pp. 16(4).
Nurco,David N.; Hanlon,Thomas E.; O’Grady,Kevin E.; Kinlock, Timothy W. (1997, November). The Early Emergence Of Narcotic Addict Types. American Journal of Drug and Alcohol Abuse, vol. 23(4), pp. 523(20).
Nurco, D. N.; Hanlon, T. E.; Balter, M. B.; Kinlock, T. W.; Slaght, E.(1991). A Classification Of Narcotic Addicts Based On Type, Amount, And Severity Of Crime. Journal on Drug Issues, vol. 21, pp. 429(19).
Nurco, D. N.; Cisin, I. H.; Balter, M. B. (1981) Addict Careers I: A New Typology. International Journal on Addiction, vol.8, pp. 1305(20).
Ross, H. E.; Glaser, F. B.; and Germanson, T. (1988). The Prevalence Of Psychiatric Disorders In Patients With Alcohol And Other Drug Problems, Arch. General Psychiatry, vol. 45, pp. 1023(8).
Rounsaville, B. J.; Weissman, M. M.; Crits-Christoph, K.; Wilber, C.; and Kleber, H.(1982). Diagnosis And Symptoms Of Depression In Opiate Addicts, Arch. General Psychiatry, vol. 39, pp. 151(5).
Schubert, D. S. P.; Wolf, A. W.; Paterson, M. B.; Grande, T. P. and Pendleton, L. (1988). A Statistical Evaluation Of The Literature Regarding The Associations Among Alcoholism, Drug Abuse And Antisocial Personality Disorder. International Journal of Addiction, vol. 23, pp. 797(11).
Sobell, L.C.; Cunningham, J.A.; Sobell, M.B. (1996) Recovery From Alcohol Problems With And Without Treatment. American Journal of Public Health, vol. 86, pp. 966(6).
Weinstein, C.S. and Shaffer, H.J. (1993). Neurocognitive Aspects Of Substance Abuse Treatment: A Psychotherapist’s Primer. Psychotheraphy, vol. 30, pp. 317(16).
Werthman, M.J. (1995, September). A Managed Care Approach To Psychological Testing: Far From Discounting Psychological Testing Entirely, Managed Care Can Enhance Its Therapeutic Usefulness. Behavioral Health Management, vol. 15(5), pp. 15(3).